Petteway Stephen R Jr

Executive VP, R&D at Talecris Biotherapeutics Holdings Corp.

Sold, on record
$3.5M
Dollars the filings state
Form 4 sales
6
Latest Feb 1, 2011
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Sep 1 2010

    Sold 25,000 shares at $21.99 ($550k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 27.7% of holdings ($2M position)65,198 shares leftFirst sale on recordFiling

  2. Oct 1 +30 days

    Sold 25,000 shares at $22.81 ($570k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 29.3% of holdings ($1.9M position)60,198 shares leftFiling

  3. Nov 1 +31 days

    Sold 25,000 shares at $24.37 ($609k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 31.2% of holdings ($2M position)55,198 shares leftFiling

  4. Dec 1 +30 days

    Sold 25,000 shares at $21.50 ($538k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 33.2% of holdings ($1.6M position)50,198 shares left1x usual sizeFiling

  5. Jan 3 +33 days

    Sold 25,000 shares at $23.06 ($577k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 35.6% of holdings ($1.6M position)45,198 shares left1x usual sizeFiling

  6. Feb 1 +29 days

    Sold 25,000 shares at $24.37 ($609k)

    Petteway Stephen R Jr, Executive VP, R&D

    Sold 38.3% of holdings ($1.6M position)40,198 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Petteway Stephen R Jr
Source
Feb 1, 2011Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$609k38.3%UnusualSEC
Jan 3, 2011Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$577k35.6%UnusualSEC
Dec 1, 2010Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$538k33.2%UnusualSEC
Nov 1, 2010Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$609k31.2%UnusualSEC
Oct 1, 2010Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$570k29.3%UnusualSEC
Sep 1, 2010Talecris Biotherapeutics Holdings Corp.Executive VP, R&DForm 4 sale25,000$550k27.7%UnusualSEC